U.S. Peripheral Artery Disease Market Size, Share, & Industry Analysis Report By Device Type (Endovascular Devices, Surgical Devices), By Anatomical Site, By End Use

Description

List of Tables

The U.S. peripheral artery disease market size is expected to reach USD 3.76 billion by 2034, according to a new study by Polaris Market Research. The report "U.S. Peripheral Artery Disease Market Share, Size, Trends, Industry Analysis Report By Device Type (Endovascular Devices, Surgical Devices), By Anatomical Site, By End Use; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Peripheral artery disease (PAD) is a circulatory condition characterized by narrowed arteries that reduce blood flow to the limbs, particularly the legs. The rising prevalence of this condition has led to a growing demand for minimally invasive endovascular interventions, which are increasingly favored due to their ability to restore perfusion with lower procedural risks and faster recovery times. These interventions, such as angioplasty and stenting, are driving clinical preference due to their effectiveness in managing complex lesions without the need for open surgery. This trend continues to shape innovation and adoption in the PAD treatment landscape as healthcare providers aim to enhance patient outcomes while optimizing resource utilization.

The U.S. peripheral artery disease market is driven by the integration of advanced clinical trial imaging and diagnostic technologies aimed at improving early detection and treatment planning. Enhanced noninvasive tools, such as duplex ultrasound devices, CT angiography, and digital health platforms, are enabling timely and accurate diagnoses, which are critical for preventing disease progression and reducing long-term complications. These advancements are contributing to more precise procedural outcomes and patient-specific therapeutic strategies. Collectively, these trends are reinforcing the shift toward more efficient and personalized care pathways in the management of PAD.

U.S. Peripheral Artery Disease Market Report Highlights

In terms of device type, the endovascular devices segment held a larger revenue share in 2024, fueled by growing patient and physician preference for minimally invasive procedures alongside continuous innovations in catheter-based treatment technologies.

Based on anatomical site, the femoropopliteal segment accounted for a substantial market share in 2024, largely driven by the frequent occurrence of atherosclerotic lesions affecting this specific vascular region.

Based on end use, the expansion of the hospital segment reflects its comprehensive vascular care capabilities, such as state-of-the-art infrastructure and specialized interventional team's adept at managing complex PAD cases.

A few key players in the U.S. peripheral artery disease market are Abbott; BD; Boston Scientific Corporation; Cook Medical; Inari Medical (Stryker); Koninklijke Philips N.V.; Medtronic; Penumbra, Inc.; Shockwave Medical, Inc.; and W. L. Gore & Associates, Inc.

Polaris Market Research has segmented the U.S. peripheral artery disease market report on the basis of device type, anatomical site, and end use:

By Device Type Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Devices

Surgical Devices

By Anatomical Site Outlook (Revenue, USD Billion, 2020-2034)

Aortoiliac

Femoropopliteal

Tibial

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Outpatient Facilities

Others

Product Code: PM6018

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. U.S. Peripheral Artery Disease Market Insights

4.1. U.S. Peripheral Artery Disease Market - Market Snapshot
4.2. U.S. Peripheral Artery Disease Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Diabetes and Obesity
  - 4.2.1.2. Rising Aging population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Excessive Treatment Costs and Poor Access to High-Technology Therapies
- 4.2.3. Public opinion and privacy legal precedents
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Peripheral Artery Disease Market Trends
4.6. Value Chain Analysis

5. U.S. Peripheral Artery Disease Market, By Device Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. U.S. Peripheral Artery Disease Market, By Device Type, 2020-2034 (USD Billion)
5.3. Endovascular Devices
- 5.3.1. U.S. Peripheral Artery Disease Market, by Endovascular Devices, by Region, 2020-2034 (USD Billion)
5.4. Surgical Devices
- 5.4.1. U.S. Peripheral Artery Disease Market, by Surgical Devices, by Region, 2020-2034 (USD Billion)

6. U.S. Peripheral Artery Disease Market, by Anatomical Site

6.1. Key Findings
6.2. Introduction
- 6.2.1. U.S. Peripheral Artery Disease Market, by Anatomical Site, 2020-2034 (USD Billion)
6.3. Aortoiliac
- 6.3.1. U.S. Peripheral Artery Disease Market, by Aortoiliac, by Region, 2020-2034 (USD Billion)
6.4. Femoropopliteal
- 6.4.1. U.S. Peripheral Artery Disease Market, by Femoropopliteal, by Region, 2020-2034 (USD Billion)
6.5. Tibial
- 6.5.1. U.S. Peripheral Artery Disease Market, by Tibial, by Region, 2020-2034 (USD Billion)

7. U.S. Peripheral Artery Disease Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. U.S. Peripheral Artery Disease Market, by End Use, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. U.S. Peripheral Artery Disease Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Outpatient Facilities
- 7.4.1. U.S. Peripheral Artery Disease Market, by Outpatient Facilities, by Region, 2020-2034 (USD Billion)
7.5. Others
- 7.5.1. U.S. Peripheral Artery Disease Market, by Others, by Region, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Abbott
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. BD
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Boston Scientific Corporation
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Cook Medical
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Inari Medical (Stryker)
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Koninklijke Philips N.V.,
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Medtronic
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Penumbra, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Shockwave Medical, Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. W. L. Gore & Associates, Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development